soul trial oral semaglutide cardiovascular outcomes Cuts Risk by 14% in Cardiovascular Outcomes, Safety, and Tolerability

Thus, as circulating L-carnitine concentration increases (as after high-dose intravenous or oral administration of L-carnitine), efficiency of reabsorption decreases and clearance increases, resulting in rapid decline of circulating L-carnitine concentration to baseline

We think that is particularly important in prostate cancer because the volume of fat that sits around the prostate is very clearly linked with poorer drug response in patients and a faster disease progression and spread outside of the prostate. GLP1 drugs are considered very effective but can cause a predictable cluster of gastrointestinal effects and a smaller set of more serious, less common risks that need watching. Medicare currently covers GLP1 drugs (like Ozempic, Mounjaro, and sometimes Wegovy/Zepbound) only when they are used for approved medical indications such as type 2 diabetes or cardiovascular risk reduction not for weight loss alone

Explore how the VitalDose Drug Delivery Platform can advance your drug pipeline: #DrugDelivery #VitalDose #WorldHealthDay2026 To view or add a comment, sign in WE CAN DO THIS ON WORLD HEALTH DAY 2026

This causes oral birth control pills to not be absorbed consistently, especially each time the dose of GLP-1/ GIP+ GLP-1 agonists are stepped up, she explained